FDA Investigator James R Evans

James R Evans has conducted inspections on 24 sites in 6 countries as of 29 Apr 2009. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
24
Last Inspection Date:
29 Apr 2009
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Canada, United States of America, France, United Kingdom of Great Britain and Northern Ireland, Spain, Austria
FDA Investigators that have inspected at least one site in common with James R Evans:
Adam R Cooke, Alanna L Mussawwir Bias, Amir Alavi, Amy S Graf, Andrea A Branche, Andrea George, PhD, Andrew C Chang, Andrew J Lang, Angel K Sandhu, Angela K Shen, Anh M Lac, Anissa M Cheung, Anita Narula, PhD, Anita R Michael, Anita Verma, Ann L Demarco, Ann Marie Montemurro, Ann Marie Schofield, Anthony F Lorenzo, Art O Czabaniuk, Ashar P Parikh, Azza Talaat, Barbara J Wilcox, PhD, Barbara M Frazier, Bei Y He, Benjamin J Dastoli, Bo Chi, PhD, Bonita S Chester, Bradley Dworak, PhD, Bryan J Love, Burnell M Henry, Calvin B Koerner, Carl Lee, Carmen Y Fisher, Carole L Jones, Carolyn A Renshaw, Carolyn A Warren, Cassandra Overking, CDR Donald Ertel, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, CDR Thomas R Berry, PPh, Christian D Lynch (CDL), Christina J Sauder, PhD, Christine A Harman, PhD, Christopher R Czajka, Christopher T Middendorf, Craig D Zagata, Cynthia Jim, CSO, Daniel C Kearns, Daniel J Brown, Daniel J Roberts, David G Eng, David J Hafner, David J Hapner, David M Beltran, David S Cho, PhD, Deborah M Trout, Debra L Pagano, Dell S Moller, Destry M Sillivan, Devaughn Edwards, Diana Kouiavskaia, Dino A Fiegelstock, Dmitriy V Volokhov, PhD, Donald C Obenhuber, PhD, Donald L Lech, Douglas J Frazier, Dr. Gang Wang, PhD, Dr. Mark J Seaton, PhD, Dr. Ralph M Bernstein, PhD, Dr. Willie F Vann, PhD, Dr. Zhihao Qiu (Peter), PhD, Dustin R Abaonza, Edmund F Mrak, Jr, Eliezar Ramos, Elizabeth Ll Edwards, Emilie E Kahn, Emily J Orban, Emily Shacter, Eric L Dong, BS, Eric Peng, Fannie M Harrell, Frederick M Lochner, Gene D Arcy, Gerald Feldman, Gerald M Feldman, PhD, Gilbert T Salud, Grace I Cortesini, Gwyn G Dickinson, Hai Lient Phung, Helen B Ricalde, Henry K Lau, Ibad U Khan, Ivan E Reyes, J David Doleski, Jacob G Lutz, Jacqueline Mdiaz Albertini, James C Maclaughlin, James E Keller, PhD, James M Mason, James W Plucinski, Janet L Bowen, Jason F Chancey, Jeanne Fringer, PhD, Jeffrey D Meng, Jeffrey M Watson, Jennifer A Longie Vollom, Jennifer L Bridgewater, Jennifer L Gustavus, Jennifer L Schmidt, Jie He, Joan A Loreng, Joan Johnson, Joan T Briones, Joey V Quitania, John D Finkbohner, PhD, John M Mcinnis, John M Mclnnis, Joohi Castelvetere, Jose Acruz Gonzalez, Joseph A Piechocki, Joseph F Owens, Joseph George, Joseph Kutze, PhD, Joseph P Iser, MD, Joseph T Madak, Joshua S Hunt, Joy Rkozlowski Klena, Julie D Bringger, Justin A Boyd, Karen M Kondas, Karen M Labounty, Kathleen D Culver, Kathryn E King, Keith O Webber, PhD, Keith Webber, PhD, Kevin P Foley, Kirsten L Vadheim, PhD, Kouros Kangarli, Kristy A Zielny, Kula N Jha, Lakisha M Williams, Lance Mde Souza, MBA, Larry K Austin, Laura I Salazar, PhD, Laureen F Kononen, Laureen M Geniusz, Laurel A Beer, Lauren M Lilly, PhD, Laurie Graham, Laurie P Norwood, LCDR Jennifer H Rhyu, Lei Zhang, PhD, Leslie D Wagner, Lewis K Antwi, Linan Ha, PhD, Lindsey Brown, PhD, Linh Tu, Lois K Gross, Lucila B Nwatu, Mabel M Lee, Maida Henesian (NMI), Marian Majors, PhD, Marie K Kinkade, Marion Michaelis, Mariza M Jafary, Mark A Elengold, Mark E Parmon, Marsha W Major, Marshalette O Edwards, Mary E Storch, Miah I Schneider, Michael E Clark, Michael P Sheehan, Michael Shanks, MS, Michael T Cyrus, Michele L Forster, PhD, Michelle Rfrazier Jessen, PhD, Mihaly S Ligmond, Milos Dokmanovic, PhD, Min Shanmabel Liu, Mohammed H Adam, Nancy T Waites, Natalia Pripuzova, PhD, Natalya M Ananyeva, Nawab A Siddiqui, Nayan J Patel, Nicholas L Hunt, Nicholas L Paulin, Nicholas Obiri, PhD, Nicole K Trudel, Nikisha M Bolden, Omotunde O Osunsanmi, Pankaj H Amin, Patricia F Hughes, PhD, Patsy J Domingo, Paul A Bonneau, Paul L Bellamy, Paul W Keller, Paula A Trost, Peter E Baker, Peter Kessler, PhD, Prabhu P Raju, Priscilla M Pastrana, Qing Joanna Zhou, PhD, Ralph A Erickson, Raymond T Oji, Rebecca E Dombrowski, Rebecca K Olin, Rebecca Rodriguez, Rebecca T Davis, Regina T Brown, Reginald D Neal, Reyes Candau Chacon, PhD, Richard Heath Coats, Richard W Thornton, Riley C Myers, PhD, Robert C Coleman, Robert D Tollefsen, Robert H Claflin, Robert Jennings, Robert Sausville, Robin Levis, PhD, Roger F Zabinski, Ronald E Lundquist, Rose Ashley, Ruth Moore, PhD, Salwa K Poole, Sandra S Saniga, Sanket N Patel, Sarah B Tanksley, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Scott E Norris, Scott N Lim, Seneca D Toms, Serge L Beaucage, Sergey S Akimov, Shafiq S Ahadi, Shankar L Saha, Sharon K Thoma, PharmD, Sheilyn H Huang, Shelley H Beausoleil, Shelley L Waring, Sherri J Jackson, Shirshendu K Deb, PhD, Sidney B Priesmeyer, Simone E Pitts, Sneha S Patel, Solomon Yimam (SY), Stephanie A Slater, MS, Stephen D Brown, Stephen J Kilker, Steven A Rubin, Steven C Derrick, Stuart W Russell, Susan F Laska, MS, Susan M Jackson, Tamara M Casselman, Tamara M Kays, Tara C Singh, Tara M Carolfi, Thea C Grome, Thomas J Arista, Thuy T Nguyen, LCDR, Timothy C Grome, Tina Buecklein, Tina M Pawlowski, Tina S Roecklein, Travis S Bradley, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), Viviana Matta, Walden H Lee, Wayne E Seifert, Wei Wang, PhD, William V Millar, Xiuju Lu, Yi Wang, PhD, Yiping Jia, Yonggang Wang, PhD, Zhao Wang, PhD

James R Evans's Documents

Publish Date Document Type Title
October, 2000 FDA 483 Instituto Grifols, S.A. - Form 483, 2000-10-11
March, 2002 FDA 483 IMTIX Sangstat - Form 483, 2002-03-21
August, 2001 EIR Genentech, Inc. - EIR, 2001-08-09
October, 2000 FDA 483 Response Baxter AG - Form 483R, 2000-10-20
June, 2000 EIR ENDO USA, Inc. - EIR, 2000-06-29
January, 2001 EIR Sanofi Pasteur Limited - EIR, 2001-02-28
March, 2000 FDA 483 Ben Venue Laboratories Inc. - Form 483, 2000-03-21
March, 2000 EIR Ben Venue Laboratories Inc. - EIR, 2000-03-21
March, 2000 FDA 483 Response Ben Venue Laboratories Inc. - Form 483R, 2000-03-31
June, 2000 FDA 483 Biogen, Inc - Form 483, 2000-06-02
October, 2000 FDA 483 Baxter Hyland Immuno - Form 483, 2000-10-03
March, 2000 FDA 483 Ben Venue Laboratories Inc. - Form 483, 2000-03-17
January, 2001 FDA 483 Aventis Pasteur Ltd. - Form 483, 2001-01-10
February, 2000 FDA 483 Corixa Corporation - Form 483, 2000-02-17
October, 2000 EIR Instituto Grifols, S.A. - EIR, 2000-10-11
March, 2001 FDA 483 Response Seqirus Vaccines Limited - Form 483R, 2001-04-20
August, 2001 FDA 483 Genentech, Inc. - Form 483, 2001-08-03
March, 2001 EIR Seqirus Vaccines Limited - EIR, 2001-04-30
June, 2000 FDA 483 ENDO USA, Inc. - Form 483, 2000-06-29
March, 2001 FDA 483 Evans Vaccines Ltd. - Form 483, 2001-03-09
October, 2000 EIR Baxter AG - EIR, 2000-10-03
February, 2000 EIR Corixa Corporation - EIR, 2000-02-17
March, 2001 FDA 483 Response Seqirus Vaccines Limited - Form 483R, 2001-04-20
August, 2000 EIR IMTIX Sangstat - EIR, 2002-03-21
March, 2000 EIR Ben Venue Laboratories Inc. - EIR, 2000-03-17
August, 2001 EIR Genentech, Inc. - EIR, 2001-08-03
March, 2002 FDA 483 Response IMTIX Sangstat - Form 483R, 2002-04-08
October, 2000 FDA 483 Response Instituto Grifols, S.A. - Form 483R, 2000-12-13
February, 2000 FDA 483 Response Corixa Corporation - Form 483R, 2000-05-03

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more